This came as Novo Nordisk India sought approval for Semaglutide tablets of 1.5 mg, 4 mg, and 9 mg of a new formulation based on the BE studies conducted in the USA and Canada. In light of earlier SEC ...

SIGNIFICANT EVENTS DURING 1 JANUARY - 31 MARCH 2025Iconovo and Lonza have entered a collaboration to develop spray-dried formulations of an intranasal biologic drug for Iconovo's proprietary intranasa ...

The country’s pharmaceuticals market grew by 8.4 per cent during financial year 2024-25 on the back of major therapies showing positive value growth, according to market research firm Pharmarack.

In India, sales of the broad category of weight-loss drugs shot up 4x over the last five years, led by the launch of Rybelsus, a tablet version of semaglutide two years ago. The segment has grown to ...

India, on its patented respiratory illness prevention technology in Dallas, TX & Quebec, Canada, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX), a company focused on ...

Saxenda – for weight loss), Dulaglutide (Trulicity), Semaglutide (Ozempic for diabetes, Wegovy for weight loss, Rybelsus oral tablet), Tirzepatide (Mounjaro – a dual GIP/GLP-1 agonist, with even ...

"It's an oral tablet, which is a much easier ... on orforglipron as rival Rybelsus (semaglutide) is as effective to control diabetes and obesity. Novo Nordisk's Rybelsus is approved for treating ...

Findings showed a 13.6% reduction in body weight in the semaglutide 25mg group compared with a 2.2% reduction in the placebo group. The Food and Drug Administration (FDA) has accepted for review ...

In India, there were 32 centres and 788 people enrolled. Semaglutide was initially approved in June 2021 for chronic weight management in those with obesity or overweight and at least one weight ...

How Long Does It Take for Semaglutide to Work? This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Semaglutide is the active ingredient in the weight loss medication Wegovy and the ...

“The results from this landmark study across 37 countries provide strong evidence that semaglutide can help patients with MASH by not only improving liver health, but also addressing the ...

Semaglutide increased maximum walking distance by 13% compared with placebo. Treatment with semaglutide improved maximum walking distance in patients with type 2 diabetes (T2D) and symptomatic ...